Business Context and Reporting Period
Oragenics, Inc. filed this Form 8-K on December 9, 2011, to report the entry into a material definitive agreement. The filing details a Fourth Amendment to an existing Unsecured Revolving Line of Credit with the Koski Family Limited Partnership (KFLP), the Company's largest shareholder and an accredited investor.
Key Financial Metrics
- Credit Facility Limit: Increased from $7,000,000 to $7,500,000.
- Recent Drawdown: $500,000 borrowed on December 9, 2011.
- Total Outstanding Debt: $7,500,000 owed to KFLP.
- Remaining Availability: $0 (fully utilized).
- Interest Rate: LIBOR plus 6.0% (based on original facility terms).
- Revenue, Profit, and Cash Flow: The filing text does not provide a clear value for these metrics.
Material Changes
The primary material change is the expansion of the Company's borrowing capacity by $500,000. This amendment was approved by the Audit Committee and disinterested directors. The Company immediately utilized the full amount of the new availability, bringing the total aggregate borrowings under the facility to $7,500,000. All other terms of the Credit Facility remained unchanged from the Third Amendment.
Outlook, Risks, and Contingencies
The filing indicates the Company has fully utilized its current credit line with no remaining availability for future draws under this specific facility. The Credit Facility includes a provision for the automatic conversion of outstanding amounts into Company securities in subsequent offerings. Additionally, the KFLP retains the right to put any undrawn available amounts to the Company, though no undrawn amounts currently exist. The filing does not provide specific management commentary on future operational outlook or new risk factors beyond the debt structure.
Investor Verification Checklist
- Verify the current LIBOR rate to calculate the exact interest expense on the $7,500,000 outstanding balance.
- Confirm the specific terms regarding the automatic conversion of debt into equity in future securities offerings.
- Review the Company's cash burn rate to assess the need for additional financing given the fully utilized credit line.
- Check for any subsequent filings regarding the maturity date of the facility, which was previously extended to July 30, 2012.